Expanding our understanding of the transport mechanisms and formate-mediated MTHFD2 in nucleotide synthesis may further refine therapeutic strategies targeting formate metabolism in metastatic cancers. This evidence concerns the gene MTHFD2 and metastatic malignant neoplasm.